212 related articles for article (PubMed ID: 32791447)
1. Living donor liver transplantation for combined hepatocellular-cholangiocarcinoma: A case series of four patients.
Ito T; Ishii T; Sumiyoshi S; Ogiso S; Fukumitsu K; Ito T; Yagi S; Seo S; Hata K; Taura K; Uemoto S
Int J Surg Case Rep; 2020; 74():46-52. PubMed ID: 32791447
[TBL] [Abstract][Full Text] [Related]
2. Multi-Center Analysis of Liver Transplantation for Combined Hepatocellular Carcinoma-Cholangiocarcinoma Liver Tumors.
Dageforde LA; Vachharajani N; Tabrizian P; Agopian V; Halazun K; Maynard E; Croome K; Nagorney D; Hong JC; Lee D; Ferrone C; Baker E; Jarnagin W; Hemming A; Schnickel G; Kimura S; Busuttil R; Lindemann J; Florman S; Holzner ML; Srouji R; Najjar M; Yohanathan L; Cheng J; Amin H; Rickert CA; Yang JD; Kim J; Pasko J; Chapman WC; Majella Doyle MB
J Am Coll Surg; 2021 Apr; 232(4):361-371. PubMed ID: 33316425
[TBL] [Abstract][Full Text] [Related]
3. Living donor liver transplantation for hepatocellular carcinoma at the University of Tokyo Hospital.
Togashi J; Akamastu N; Kokudo N
Hepatobiliary Surg Nutr; 2016 Oct; 5(5):399-407. PubMed ID: 27826554
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological features and recurrence patterns of combined hepatocellular-cholangiocarcinoma.
Ishii T; Ito T; Sumiyoshi S; Ogiso S; Fukumitsu K; Seo S; Taura K; Uemoto S
World J Surg Oncol; 2020 Dec; 18(1):319. PubMed ID: 33276780
[TBL] [Abstract][Full Text] [Related]
5. An international multicentre evaluation of treatment strategies for combined hepatocellular-cholangiocarcinoma
Claasen MPAW; Ivanics T; Beumer BR; de Wilde RF; Polak WG; Sapisochin G; IJzermans JNM
JHEP Rep; 2023 Jun; 5(6):100745. PubMed ID: 37234277
[TBL] [Abstract][Full Text] [Related]
6. Living-donor liver transplantation for hepatocellular carcinoma.
Kaihara S; Kiuchi T; Ueda M; Oike F; Fujimoto Y; Ogawa K; Kozaki K; Tanaka K
Transplantation; 2003 Feb; 75(3 Suppl):S37-40. PubMed ID: 12589138
[TBL] [Abstract][Full Text] [Related]
7. Radiological features and outcomes of combined hepatocellular-cholangiocarcinoma in patients undergoing surgical resection.
Chi CT; Chau GY; Lee RC; Chen YY; Lei HJ; Hou MC; Chao Y; Huang YH
J Formos Med Assoc; 2020 Jan; 119(1 Pt 1):125-133. PubMed ID: 30876788
[TBL] [Abstract][Full Text] [Related]
8. Combined hepatocellular-cholangiocarcinoma and its mimickers: Diagnostic pitfalls in surgical pathology.
Laohawetwanit T; Lerttanatum N; Wanpiyarat N; Manasilp N; Chaiparnich S
Ann Diagn Pathol; 2021 Aug; 53():151770. PubMed ID: 34147845
[TBL] [Abstract][Full Text] [Related]
9. Combined hepatocellular-cholangiocarcinoma derives from liver progenitor cells and depends on senescence and IL-6 trans-signaling.
Rosenberg N; Van Haele M; Lanton T; Brashi N; Bromberg Z; Adler H; Giladi H; Peled A; Goldenberg DS; Axelrod JH; Simerzin A; Chai C; Paldor M; Markezana A; Yaish D; Shemulian Z; Gross D; Barnoy S; Gefen M; Amran O; Claerhout S; Fernández-Vaquero M; García-Beccaria M; Heide D; Shoshkes-Carmel M; Schmidt Arras D; Elgavish S; Nevo Y; Benyamini H; Tirnitz-Parker JEE; Sanchez A; Herrera B; Safadi R; Kaestner KH; Rose-John S; Roskams T; Heikenwalder M; Galun E
J Hepatol; 2022 Dec; 77(6):1631-1641. PubMed ID: 35988690
[TBL] [Abstract][Full Text] [Related]
10. Living Donor Liver Transplantation Outcomes for Hepatocellular Carcinoma Beyond Milan or UCSF Criteria.
Gunay Y; Guler N; Yaprak O; Dayangac M; Akyildiz M; Altaca G; Yuzer Y; Tokat Y
Indian J Surg; 2015 Dec; 77(Suppl 3):950-6. PubMed ID: 27011489
[TBL] [Abstract][Full Text] [Related]
11. Liver transplantation for intrahepatic cholangiocarcinoma.
Lee DD; Croome KP; Musto KR; Melendez J; Tranesh G; Nakhleh R; Taner CB; Nguyen JH; Patel T; Harnois DM
Liver Transpl; 2018 May; 24(5):634-644. PubMed ID: 29514406
[TBL] [Abstract][Full Text] [Related]
12. Can living donor liver transplantation offer similar outcomes to deceased donor liver transplantation using expanded selection criteria for hepatocellular carcinoma?
Chen LP; Li C; Wen TF; Yan LN; Li B; Yang JY
Pak J Med Sci; 2015; 31(4):763-9. PubMed ID: 26430399
[TBL] [Abstract][Full Text] [Related]
13. Salvage living donor liver transplantation for post-resection recurrence of combined hepatocellular carcinoma-cholangiocarcinoma.
Kim M; Hwang S; Song GW; Ahn CS; Moon DB; Jung DH; Park GC; Lee SG
Korean J Transplant; 2021 Jun; 35(2):116-123. PubMed ID: 35769525
[TBL] [Abstract][Full Text] [Related]
14. Genomic Profiling of Combined Hepatocellular Cholangiocarcinoma Reveals Genomics Similar to Either Hepatocellular Carcinoma or Cholangiocarcinoma.
Murugesan K; Sharaf R; Montesion M; Moore JA; Pao J; Pavlick DC; Frampton GM; Upadhyay VA; Alexander BM; Miller VA; Javle MM; Bekaii Saab TS; Albacker LA; Ross JS; Ali SM
JCO Precis Oncol; 2021 Aug; 5():. PubMed ID: 34476330
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcome of living-donor liver transplantation for combined hepatocellular-cholangiocarcinoma.
Itoh S; Ikegami T; Yoshizumi T; Wang H; Takeishi K; Harimoto N; Yamashita Y; Kawanaka H; Aishima S; Shirabe K; Maehara Y
Anticancer Res; 2015 Apr; 35(4):2475-6. PubMed ID: 25862916
[TBL] [Abstract][Full Text] [Related]
16. Update on the Diagnosis and Treatment of Combined Hepatocellular Cholangiocarcinoma.
Chu KJ; Kawaguchi Y; Wang H; Jiang XQ; Hasegawa K
J Clin Transl Hepatol; 2024 Feb; 12(2):210-217. PubMed ID: 38343605
[TBL] [Abstract][Full Text] [Related]
17. How to utilize LR-M features of the LI-RADS to improve the diagnosis of combined hepatocellular-cholangiocarcinoma on gadoxetate-enhanced MRI?
Lee HS; Kim MJ; An C
Eur Radiol; 2019 May; 29(5):2408-2416. PubMed ID: 30552477
[TBL] [Abstract][Full Text] [Related]
18. Section 5. Further expanding the criteria for HCC in living donor liver transplantation: when not to transplant: SNUH experience.
Lee KW; Yi NJ; Suh KS
Transplantation; 2014 Apr; 97 Suppl 8():S20-3. PubMed ID: 24849825
[TBL] [Abstract][Full Text] [Related]
19. Examinations of Factors Influencing Survival of Liver Transplantation for Hepatocellular Carcinoma: A Single-Center Experience From Budapest.
Piros L; Fehérvári I; Görög D; Nemes B; Szabó J; Gerlei Z; Végső G; Kóbori L; Máthé Z
Transplant Proc; 2015 Sep; 47(7):2201-6. PubMed ID: 26361680
[TBL] [Abstract][Full Text] [Related]
20. Outcome of ABO-incompatible adult living-donor liver transplantation for patients with hepatocellular carcinoma.
Yoon YI; Song GW; Lee SG; Hwang S; Kim KH; Kim SH; Kang WH; Cho HD; Jwa EK; Kwon JH; Tak EY; Kirchner VA
J Hepatol; 2018 Jun; 68(6):1153-1162. PubMed ID: 29452208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]